GCM Commodity (535917)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Current market price of ₹6.25 is at the upper end of the 52-week range (₹3.30–₹6.25), showing some market participants are willing to pay up.
• Market cap of ₹5 Cr is tiny, so a successful turnaround could create a large percentage gain if the business ever generates genuine earnings.
• The company pays no dividend, meaning there is no cash outflow to shareholders while it faces losses.

Concerns

• Latest quarter has zero sales and a net loss of ₹2 Cr, so the business is currently consuming cash with no revenue.
• ROCE is -49.66% and profit growth is -732.26%, indicating severe operational deterioration.
• Piotroski F-Score of 2/9 is very poor, suggesting weak financial health and a low probability of near-term improvement.
• P/E is 0.00, and book value, debt/equity, and promoter holding are unavailable, so an investor cannot calculate any margin of safety.

AI Analysis

What can I say about GCM Commodity? The numbers fail every test I would apply. The latest quarter shows sales of ₹0 crore and a net loss of ₹2 crore. With a market capitalisation of just ₹5 crore, the entire business is roughly valued at only two and a half times one quarter's losses. There is no positive earnings to capitalise, so the P/E is meaningless at 0.00. Return on capital employed is deeply negative at -49.66%, and profit growth has deteriorated by -732.26%. This is not a business; it is a cash incinerator. The Piotroski F-score of 2 out of 9 tells me that nearly every fundamental indicator is deteriorating. There is no dividend, no recorded sales growth, no promoter holding, and no book value I can trust. Graham would say the margin of safety is impossible to calculate when the asset base is unknown. Buffett would say a great management team is not enough when the economics are bad; here, we cannot even evaluate management. The price at ₹6.25 is at the top of the 52-week range, but a rising share price without rising earnings is speculation, not investment. Some might argue this is a turnaround because the market cap is so small and the shares are near their high. But a turnaround requires a credible plan, revenue, and a path to profitability. None of those appear in the figures. I would not be a willing buyer at any price unless I saw massive disclosure, a real business model, and evidence that shareholder capital is being protected. In the words of my partner Charlie Munger, 'A great business at a fair price is far better than a fair business at a great price.' This is neither great nor fair.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer